Retina Partners Midwest, P.C.

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Macular degeneration2 trials

Phase

• Phase 21 trial
• Phase 2/31 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• Ocugen1 trial
• Ocular Therapeutix, Inc.1 trial
• ONL Therapeutics1 trial

Running trials

• Recruiting

  Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  NCT06659445· Phase 2· ONL Therapeutics· Source

  Contact: Study Coordinator

• Active, not recruiting

  Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration

  NCT06495918· Phase 3· Ocular Therapeutix, Inc.· Source

• Active, not recruiting

  A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease

  NCT05956626· Phase 2/3· Ocugen· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Macular degeneration1 recruiting